Assessment of a new score for capsule endoscopy in pediatric Crohnʼs disease (CE-CD)

Abstract

Background and study aims Two scores have been implemented to standardize capsule endoscopic (CE) findings in patients with Crohn’s disease (CD): Lewis score (LS) and Capsule Endoscopy Crohnʼs Disease Activity Index (CECDAI). Both have limitations and are not well validated in the pediatric population. The aim of our study was to assess a new score (capsule endoscopy – Crohn’s disease index, CE-CD) in pediatric patients with CD and to compare it to preexisting scores.

Patients and methods This was a double-center, retrospective study involving pediatric subjects with CD who underwent CE. Correlation analyses between CE-CD, endoscopy scores and noninvasive markers of disease activities were performed. The ability of different CE scores to predict clinical and endoscopic outcomes was evaluated with regression and survival analyses.

Results A total of 312 subjects were analyzed. The CE-CD score showed a moderate (Pearson’s r = 0.581, P < 0.001) and strong (r = 0.909, P < 0.001) association with LS and CECDAI, respectively. CE-CD was a statistically significant predictor of hospitalization (hazard ratio [HR]1.061), treatment escalation (HR 1.062), steroid therapy (HR 1.082), clinical (HR 1.064) and endoscopic (HR 1.060) relapse over the twenty-four months (P < 0.001). Subjects with mucosal inflammation according to CE-CD (CE-CD ≥ 9) had worse outcomes compared to patients without inflammation (CE-CD < 9) (Log rang test < 0.001).

Conclusions The CE-CD score is a simple, reliable, reproducible, and predictive score for evaluation of small bowel inflammation in pediatric patients with CD. Prospective validation is needed to confirm the applicability of this new index in clinical practice.

Publikationsverlauf

Eingereicht: 10. November 2020

Angenommen: 12. März 2021

Artikel online veröffentlicht:
16. September 2021

• References

• 1 Rosen MJ, Dhawan A, Saeed SA. Inflammatory bowel disease in children and adolescents. JAMA Pediatr 2015; 169: 1053-1060
• 2 Oliva S, Thomson M, de Ridder L. et al. Endoscopy in pediatric inflammatory bowel disease: A position paper on behalf of the Porto IBD Group of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2018; 67: 414-530
• 3 Pennazio M, Spada C, Eliakim R. et al. Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy 2015; 47: 352-376
• 4 Jensen MD, Nathan T, Rafaelsen SR. et al. Diagnostic accuracy of capsule endoscopy for small bowel Crohnʼs disease is superior to that of MR enterography or CT enterography. Clin Gastroenterol Hepatol 2011; 9: 124-129
• 5 Greener T, Klang E, Yablecovitch D. et al. The impact of magnetic resonance enterography and capsule endoscopy on the re-classification of disease in patients with known Crohnʼs disease: A prospective Israeli IBD Research Nucleus (IIRN) study. J Crohns Colitis 2016; 10: 525-531
• 6 Gralnek IM, Defranchis R, Seidman E. et al. Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change. Aliment Pharmacol Ther 2008; 27: 146-154
• 7 Niv Y, Ilani S, Levi Z. et al. Validation of the capsule endoscopy Crohnʼs disease activity index (CECDAI or Niv score): a multicenter prospective study. Endoscopy 2012; 44: 21-26
• 8 Omori T, Kambayashi H, Murasugi S. et al. Comparison of Lewis score and capsule endoscopy Crohnʼs disease activity index in patients with Crohnʼs disease. Dig Dis Sci 2020; 65: 1180-1188
• 9 Shah SC, Colombel JF, Sands BE. et al. Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohnʼs disease. Aliment Pharmacol Ther 2016; 43: 317-333
• 10 Vaughn BP, Shah S, Cheifetz AS. The role of mucosal healing in the treatment of patients with inflammatory bowel disease. Curr Treat Options Gastroenterol 2014; 12: 103-117
• 11 Orlando A, Guglielmi FW, Cottone M. et al. Clinical implications of mucosal healing in the management of patients with inflammatory bowel disease. Dig Liver Dis 2013; 45: 986-991
• 12 Daperno M, Comberlato M, Bossa F. et al. Training programs on endoscopic scoring systems for inflammatory bowel disease lead to a significant increase in interobserver agreement among community gastroenterologists. J Crohns Colitis 2017; 11: 556-561
• 13 Daperno M, D'Haens G, Van Assche G. et al. Development and validation of a new, simplified endoscopic activity score for Crohnʼs disease: the SES-CD. Gastrointest Endosc 2004; 60: 505-512
• 14 Hyams JS, Ferry GD, Mandel FS. et al. Development and validation of a pediatric Crohnʼs disease activity index. J Pediatr Gastroenterol Nutr 1991; 12: 439-447
• 15 Gal E, Geller A, Fraser G. et al. Assessment and validation of the new capsule endoscopy Crohnʼs disease activity index (CECDAI). Dig Dis Sci 2008; 53: 1933-1937
• 16 Koulaouzidis A, Nemeth A, Johansson GW. et al. Dissecting Lewis score under the light of fecal calprotectin; an analysis of correlation of score components with calprotectin levels in capsule endoscopy. Ann Gastroenterol 2015; 28: 259-264
• 17 Koulaouzidis A, Sipponen T, Nemeth A. et al. Association between fecal calprotectin levels and small-bowel inflammation score in capsule endoscopy: a multicenter retrospective study. Dig Dis Sci 2016; 61: 2033-2040
• 18 Yablecovitch D, Lahat A, Neuman S. et al. The Lewis score or the capsule endoscopy Crohnʼs disease activity index: which one is better for the assessment of small bowel inflammation in established Crohnʼs disease?. Therap Adv Gastroenterol 2018; 11
• 19 Rokkas T, Portincasa P, Koutroubakis IE. Fecal calprotectin in assessing inflammatory bowel disease endoscopic activity: a diagnostic accuracy meta-analysis. J Gastrointestin Liver Dis 2018; 27: 299-306
• 20 Monteiro S, Barbosa M, Cúrdia Gonçalves T. et al. Fecal calprotectin as a selection tool for small bowel capsule endoscopy in suspected Crohnʼs disease. Inflamm Bowel Dis 2018; 24: 2033-2038
• 21 Sorrentino D, Nguyen VQ. Clinically significant small bowel Crohnʼs disease might only be detected by capsule endoscopy. Inflamm Bowel Dis 2018; 24: 1566-1574
• 22 Hansel SL, McCurdy JD, Barlow JM. et al. Clinical benefit of capsule endoscopy in crohnʼs disease: impact on patient management and prevalence of proximal small bowel involvement. Inflamm Bowel Dis 2018; 24: 1582-1588
• 23 Kopylov U, Yablecovitch D, Lahat A. et al. Detection of small bowel mucosal healing and deep remission in patients with known small bowel Crohnʼs disease using biomarkers, capsule endoscopy, and imaging. Am J Gastroenterol 2015; 110: 1316-1323
• 24 Niv Y. Small-bowel mucosal healing assessment by capsule endoscopy as a predictor of long-term clinical remission in patients with Crohnʼs disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2017; 29: 844-848
• 25 Nishikawa T, Nakamura M, Yamamura T. et al. Lewis Score on capsule endoscopy as a predictor of the risk for Crohnʼs disease-related emergency hospitalization and clinical relapse in patients with small bowel Crohnʼs Disease. Gastroenterol Res Pract 2019; 2019: 4274257
• 26 Ben-Horin S, Lahat A, Amitai MM. et al. Assessment of small bowel mucosal healing by video capsule endoscopy for the prediction of short-term and long-term risk of Crohnʼs disease flare: a prospective cohort study. Lancet Gastroenterol Hepatol 2019; 4: 519-528
• 27 Mow WS, Lo SK, Targan SR. et al. Initial experience with wireless capsule enteroscopy in the diagnosis and management of inflammatory bowel disease. Clin Gastroenterol Hepatol 2004; 2: 31-40